Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Zomedica Aims to Specialize in Pet Pharma

Monday, August 29, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

Ann Arbor startup raises funding for animal-specific drug development


Zomedica Pharmaceuticals Corp., an Ann Arbor startup that is developing drugs for cats, dogs and horses, announced last week that it has finished raising the first segment of a private offering of $15 million Canadian, or the equivalent of about $11.7 million U.S.

The company said it has sold more than 3.3 million shares of common stock at $1.50 Canadian for total proceeds of just over $5 million Canadian, or about $4 million U.S.

The company, whose drug development is still in the early stages, is part of a growing array of startups seeking to develop drugs tailored to specific animals, rather than repurposing human drugs.

Company President and CEO Gerald Solensky Jr. told Crain's Friday that he expects to finish the offering in the next month or so.

"We're targeting both new and existing investors, and we'll finish fundraising very quickly," he said. "This financing strongly positions Zomedica to hit the key milestones that we have communicated to the public markets."

Read full article.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal